CN117642631A - 含有tarc的组合物、稀释剂、减少tarc残留的方法、吸附抑制剂和连续分析方法 - Google Patents

含有tarc的组合物、稀释剂、减少tarc残留的方法、吸附抑制剂和连续分析方法 Download PDF

Info

Publication number
CN117642631A
CN117642631A CN202280046998.1A CN202280046998A CN117642631A CN 117642631 A CN117642631 A CN 117642631A CN 202280046998 A CN202280046998 A CN 202280046998A CN 117642631 A CN117642631 A CN 117642631A
Authority
CN
China
Prior art keywords
tarc
sample
acidic
composition
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280046998.1A
Other languages
English (en)
Chinese (zh)
Inventor
藤村建午
佐佐木龙太
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Medical Co Ltd
Original Assignee
Sekisui Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd filed Critical Sekisui Medical Co Ltd
Publication of CN117642631A publication Critical patent/CN117642631A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/521—Chemokines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202280046998.1A 2021-07-15 2022-07-14 含有tarc的组合物、稀释剂、减少tarc残留的方法、吸附抑制剂和连续分析方法 Pending CN117642631A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021116842 2021-07-15
JP2021-116842 2021-07-15
PCT/JP2022/027642 WO2023286821A1 (ja) 2021-07-15 2022-07-14 Ｔａｒｃを含有する組成物、希釈液、ｔａｒｃのキャリーオーバー抑制方法、吸着防止剤、及び連続的分析方法

Publications (1)

Publication Number Publication Date
CN117642631A true CN117642631A (zh) 2024-03-01

Family

ID=84920291

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280046998.1A Pending CN117642631A (zh) 2021-07-15 2022-07-14 含有tarc的组合物、稀释剂、减少tarc残留的方法、吸附抑制剂和连续分析方法

Country Status (5)

Country Link
US (1) US20240319206A1 (https=)
EP (1) EP4365592A4 (https=)
JP (1) JPWO2023286821A1 (https=)
CN (1) CN117642631A (https=)
WO (1) WO2023286821A1 (https=)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2645805B2 (ja) 1994-06-22 1997-08-25 三洋化成工業株式会社 抗原含有水溶液
JP3687993B2 (ja) 1994-06-24 2005-08-24 シスメックス株式会社 インシュリン標準液
ES2233978T3 (es) * 1995-09-27 2005-06-16 SHIONOGI & CO., LTD. Proteina analoga a la quimiocina de tipo cc.
JP2000206117A (ja) * 1999-01-14 2000-07-28 Wakamoto Pharmaceut Co Ltd ヒトヘモグロビンの安定化方法
JP5065237B2 (ja) * 2008-12-26 2012-10-31 常盤薬品工業株式会社 アトピー性皮膚炎の局所病態の非侵襲的評価方法
JP5832723B2 (ja) 2009-03-06 2015-12-16 協和メデックス株式会社 可溶性インターロイキン−２受容体定量用標準品
KR20170018810A (ko) * 2014-06-10 2017-02-20 메이지 세이카 파루마 가부시키가이샤 안정한 아달리무맙 수성 제제
CN105462929B (zh) * 2014-06-13 2019-11-22 中国人民解放军军事医学科学院毒物药物研究所 一种筛选ccr4拮抗剂的细胞模型及筛选方法
CN105770893B (zh) * 2014-12-17 2019-04-05 中国科学院宁波材料技术与工程研究所 一种铋基复合纳米材料及其肿瘤诊断与治疗应用
JP6409016B2 (ja) 2016-03-31 2018-10-17 積水メディカル株式会社 ラテックス免疫凝集法における測定誤差低減方法
JP2018163149A (ja) * 2017-03-27 2018-10-18 三洋化成工業株式会社 抗原含有水溶液の製造方法及び免疫測定方法
JP7281070B2 (ja) 2019-01-18 2023-05-25 京セラドキュメントソリューションズ株式会社 サーバー装置、メンテナンス管理システム及びメンテナンス管理プログラム
JP7065046B2 (ja) 2019-01-18 2022-05-11 ヤンマーパワーテクノロジー株式会社 作業情報管理装置および作業情報共有化方法
JP2020119024A (ja) 2019-01-18 2020-08-06 ソニー株式会社 情報処理装置、情報処理方法、及び、記録媒体
JP7346998B2 (ja) * 2019-08-21 2023-09-20 東ソー株式会社 表面修飾磁性粒子及びその製造方法

Also Published As

Publication number Publication date
US20240319206A1 (en) 2024-09-26
WO2023286821A1 (ja) 2023-01-19
EP4365592A1 (en) 2024-05-08
EP4365592A4 (en) 2025-10-08
JPWO2023286821A1 (https=) 2023-01-19

Similar Documents

Publication Publication Date Title
CN111679086B (zh) 一种hbp的磁微粒化学发光法检测试剂盒及其制备方法
CN109613259A (zh) 一种高灵敏度、宽检测范围的人肝素结合蛋白测定试剂盒
CN108152512A (zh) 肝素结合蛋白检测试剂盒及其制备方法
CN109633148B (zh) Kl-6检测乳胶凝集试剂
KR20160014007A (ko) 면역 응집 측정법
US9046517B2 (en) Cystatin C adsorption inhibitor
JP5789520B2 (ja) ヒトｓＣＤ１４−ＳＴの分析方法
JP6736797B1 (ja) 自動分析装置での免疫測定における異常検出抑制方法、及び免疫測定試薬
JPH06300761A (ja) 免疫比濁測定試薬及び測定方法
CN117642631A (zh) 含有tarc的组合物、稀释剂、减少tarc残留的方法、吸附抑制剂和连续分析方法
JP4095888B2 (ja) 免疫学的分析試薬及び免疫学的分析方法
CN115015533B (zh) 一种氧化低密度脂蛋白测定试剂盒
TWI899280B (zh) 含有tarc之組成物及tarc之保存穩定性之提升方法
WO2023190275A1 (ja) ラテックス粒子分散液
GB2217335A (en) Compositions for isolation and immobilisation of C-reactive protein in body liquids
TWI893163B (zh) 含有ｔａｒｃ之組成物以及其用途、及ｔａｒｃ之保存穩定性之提昇方法
CN115524481B (zh) 通过荧光免疫层析检测技术测定单克隆抗体亲和力的方法
TWI900607B (zh) 含有tarc之組成物及tarc之保存穩定性之提升方法
WO2022154121A1 (ja) ヘプシジンの吸着抑制剤、吸着抑制方法、標準品、試薬、キットおよび測定方法
JPH08233816A (ja) 免疫学的測定法
CN115777065A (zh) 含有tarc的组合物和用于改善tarc的储存稳定性的方法
CN121794574A (zh) 胶乳粒子分散液、试剂盒、检测方法、沉降抑制剂及沉降抑制方法
CN115777066A (zh) 含有tarc的组合物和改善tarc储存稳定性的方法
JPH09189697A (ja) 検量体物質が変性溶液中に存在する、免疫アツセイを実施するための方法
WO2020203755A1 (ja) 免疫測定試薬及び免疫測定方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination